These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37503496)

  • 1. Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review.
    Dhamija D; Bello AO; Khan AA; Gutlapalli SD; Sohail M; Patel PA; Midha S; Shukla S; Mohammed L
    Cureus; 2023 Jun; 15(6):e40969. PubMed ID: 37503496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study.
    Mansell H; Quinn D; Kelly LE; Szafron M; Alcorn J
    JMIR Res Protoc; 2021 Oct; 10(10):e31281. PubMed ID: 34661540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review.
    Patel S; Khan S; M S; Hamid P
    Cureus; 2020 Jul; 12(7):e9309. PubMed ID: 32839678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis.
    Ahlers J; Baumgartner C; Augsburger M; Wenger A; Malischnig D; Boumparis N; Berger T; Stark L; Ebert DD; Haug S; Schaub MP
    J Med Internet Res; 2022 Apr; 24(4):e30138. PubMed ID: 35442196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review.
    Francisco AP; Lethbridge G; Patterson B; Goldman Bergmann C; Van Ameringen M
    J Psychiatr Res; 2023 Jan; 157():239-256. PubMed ID: 36508935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis.
    Froude AM; Fawcett EJ; Coles A; Drakes DH; Harris N; Fawcett JM
    J Psychiatr Res; 2024 Apr; 172():391-401. PubMed ID: 38452637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review.
    Mckenzie A; Meshkat S; Lui LMW; Ho R; Di Vincenzo JD; Ceban F; Cao B; McIntyre RS
    J Psychiatr Res; 2022 May; 149():252-259. PubMed ID: 35303614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Suicide Risk of Children and Adolescents With Attention Deficit and Hyperactivity Disorder-A Systematic Review.
    Garas P; Balazs J
    Front Psychiatry; 2020; 11():557909. PubMed ID: 33408650
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
    BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction.
    Stueber A; Cuttler C
    J Atten Disord; 2022 Apr; 26(6):942-955. PubMed ID: 34632827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress as a mediator of brain alterations in attention-deficit hyperactivity disorder: A systematic review.
    Koppelmaa K; Yde Ohki CM; Walter NM; Walitza S; Grünblatt E
    Compr Psychiatry; 2024 Apr; 130():152454. PubMed ID: 38281339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit hyperactivity disorder and restless leg syndrome across the lifespan: A systematic review and meta-analysis.
    Migueis DP; Lopes MC; Casella E; Soares PV; Soster L; Spruyt K
    Sleep Med Rev; 2023 Jun; 69():101770. PubMed ID: 36924608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis.
    Asbjornsdottir B; Snorradottir H; Andresdottir E; Fasano A; Lauth B; Gudmundsson LS; Gottfredsson M; Halldorsson TI; Birgisdottir BE
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies.
    Khoshbakht Y; Bidaki R; Salehi-Abargouei A
    Adv Nutr; 2018 Jan; 9(1):9-20. PubMed ID: 29438455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.